FDA Approves First-Ever Treatment for Acquired Hypothalamic Obesity – IMCIVREE Now Available

Rhythm Pharmaceuticals receives FDA approval for IMCIVREE (setmelanotide) — the first and only treatment for acquired hypothalamic obesity.